<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01840800</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2012-063</org_study_id>
    <nct_id>NCT01840800</nct_id>
  </id_info>
  <brief_title>USG Nerve Blocks for ACL Reconstruction</brief_title>
  <official_title>Ultrasound Guided Nerve Block Combinations for Anterior Cruciate Ligament Reconstruction; Femoral, Saphenous and Obturator (Posterior Branch)Nerves.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jens Borglum Neimann</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anterior cruciate ligament reconstruction is a routine surgical procedure. Traditional
      femoral/sciatic block combinations effectively reduce postoperative pain, but results in
      considerable motor blockade. The investigators aimed to evaluate postoperative pain relief
      and the degree of motor block with block combinations of femoral nerve (FEM) and obturator
      [posterior branch] nerve (ONP), versus saphenous nerve (SAPH) and ONP, versus placebo blocks
      with isotonic saline. All patients received standard patient controlled analgesia with
      morphine.Randomized, placebo-controlled and double-blinded clinical trial. Following IRB
      approval, 81 patients were planned to be randomized to one of three USG block combinations:
      Active FEM+ONP, active SAPH+ONP or no active blocks (sham blocks) Ropivacaine 0.75% was used
      for all active blocks following induction of general anaesthesia [propofol-remifentanil,
      laryngeal mask airway]. Primary outcome measure: Localized PACU pain scores (AUC) 0-6 hours
      postoperatively at rest.

      Secondary outcome measures: Opioid consumption, opioid related side effects, PACU time, motor
      abilities of daily living scores [modified Barthel/100 index], perceived ill health [Short
      form-8] scores and degree of motor blockade [Jensen- Børglum motor test].
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">June 2014</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>NRS (pain score)</measure>
    <time_frame>Area under the curve (AUC) 0-6 hours postoperatively</time_frame>
    <description>Numerical rating scale(0-10)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>0-6 hours postoperatively</time_frame>
    <description>Opioid consumption (PCA pump - mg of morphine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>opioid related side effects</measure>
    <time_frame>0-6 hours postoperatively</time_frame>
    <description>Nausea (0-3), vomiting (&gt;10 ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PACU time</measure>
    <time_frame>0-6 hours postoperatively</time_frame>
    <description>Minutes in PACU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor abilities of of daily living</measure>
    <time_frame>0-24 hours postoperatively</time_frame>
    <description>Modified Barthel/100 index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived ill health</measure>
    <time_frame>0-24 hours postoperatively</time_frame>
    <description>Short-Form-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of motor block.</measure>
    <time_frame>0-6 hours postoperatively</time_frame>
    <description>Jensen-Borglum motor test</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">82</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Active FEM+ONP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nerveblock of n. femoralis (FEM) with 10 ml Ropivacaine 7.5 mg/ml and nerveblock of obturator nerveposterior branch (ONP) with 10 ml Ropivacaine 7.5 mg/ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active SAPH+ONP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nerveblock of n.saphenous (SAPH) with 5 ml Ropivacaine 7.5 mg/ml and nerveblock of obturator nerve, posterior branch (ONP) with 10 ml Ropivacaine 7.5 mg/ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline 9 mg/ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <arm_group_label>Active FEM+ONP</arm_group_label>
    <arm_group_label>Active SAPH+ONP</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years.

          -  Isolated primary ACL reconstruction in general anaesthesia with hamstring graft.

          -  ASA 1-3.

          -  Written and informed consent to study protocol.

        Exclusion Criteria:

          -  ACL reconstruction with patellar tendon graft

          -  Uncooperative patients.

          -  Patients that do not understand or speak danish.

          -  Daily use of opioids equivalent to &gt; 40 mg morphine.

          -  Allergic to Ropivacaine.

          -  Alcohol abusers

          -  Contraindications to general anaesthesia.

          -  Pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bispebjerg Hospital, department of anesthesiology</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2013</study_first_submitted>
  <study_first_submitted_qc>April 25, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 26, 2013</study_first_posted>
  <last_update_submitted>July 30, 2014</last_update_submitted>
  <last_update_submitted_qc>July 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 31, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Jens Borglum Neimann</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Postoperative pain</keyword>
  <keyword>anterior cruciate ligament reconstruction</keyword>
  <keyword>ultrasound guided nerve blocks</keyword>
  <keyword>opioid consumption</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

